Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07490522Not ApplicableRecruiting

The Remote Monitoring of Gout Feasibility Study in Primary Care

Role: collaborator

NCT06644482Not ApplicableCompleted

Exercise as Treatment for Patients With Inclusion Body Myositis

Role: collaborator

NCT04922840Not ApplicableCompleted

Improved Cardiovascular Health for Patients With Inflammatory Joint Diseases

Role: collaborator

NCT05150171Not ApplicableCompleted

Happy Hands E-self-management Pilot Study

Role: collaborator

NCT04084834Not ApplicableCompleted

Feasibility of a Web-based, Peer-supported Exercise Program for Patients With Hip and/or Knee Osteoarthritis

Role: collaborator

NCT01205854Phase 4Completed

Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial

Role: collaborator

All 6 trials loaded